These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 28727430)
1. Renal Clearable Peptide Functionalized NaGdF Chen H; Li X; Liu F; Zhang H; Wang Z Mol Pharm; 2017 Sep; 14(9):3134-3141. PubMed ID: 28727430 [TBL] [Abstract][Full Text] [Related]
2. Employing antagonistic C-X-C motif chemokine receptor 4 antagonistic peptide functionalized NaGdF Li X; Bao Y; Li Z; Teng P; Ma L; Zhang H; Liu G; Wang Z Sci Rep; 2024 Jul; 14(1):15764. PubMed ID: 38982161 [TBL] [Abstract][Full Text] [Related]
3. Employing Tryptone as a General Phase Transfer Agent to Produce Renal Clearable Nanodots for Bioimaging. Liu F; He X; Zhang J; Zhang H; Wang Z Small; 2015 Aug; 11(30):3676-85. PubMed ID: 25914195 [TBL] [Abstract][Full Text] [Related]
4. Renal-clearable hyaluronic acid functionalized NaGdF Yan Y; Ding L; Liu L; Abualrejal MMA; Chen H; Wang Z RSC Adv; 2020 Apr; 10(23):13872-13878. PubMed ID: 35492986 [TBL] [Abstract][Full Text] [Related]
5. Peptide-enhanced tumor accumulation of upconversion nanoparticles for sensitive upconversion luminescence/magnetic resonance dual-mode bioimaging of colorectal tumors. Li X; Liu L; Fu Y; Chen H; Abualrejal MMA; Zhang H; Wang Z; Zhang H Acta Biomater; 2020 Mar; 104():167-175. PubMed ID: 31923719 [TBL] [Abstract][Full Text] [Related]
6. Integrating Anatomic and Functional Dual-Mode Magnetic Resonance Imaging: Design and Applicability of a Bifunctional Contrast Agent. Ni D; Shen Z; Zhang J; Zhang C; Wu R; Liu J; Yi M; Wang J; Yao Z; Bu W; Shi J ACS Nano; 2016 Mar; 10(3):3783-90. PubMed ID: 26910513 [TBL] [Abstract][Full Text] [Related]
7. Peptide-functionalized NaGdF Chen Y; Fu Y; Li X; Chen H; Wang Z; Zhang H RSC Adv; 2019 May; 9(30):17093-17100. PubMed ID: 35519897 [TBL] [Abstract][Full Text] [Related]
8. Gadolinium-loaded calcium phosphate nanoparticles for magnetic resonance imaging of orthotopic hepatocarcinoma and primary hepatocellular carcinoma. Zhang NN; Lu CY; Shu GF; Li J; Chen MJ; Chen CM; Lv XL; Xu XL; Weng W; Weng QY; Tang BF; Du YZ; Ji JS Biomater Sci; 2020 Mar; 8(7):1961-1972. PubMed ID: 32064471 [TBL] [Abstract][Full Text] [Related]
9. Ultrasmall NaGdF4 nanodots for efficient MR angiography and atherosclerotic plaque imaging. Xing H; Zhang S; Bu W; Zheng X; Wang L; Xiao Q; Ni D; Zhang J; Zhou L; Peng W; Zhao K; Hua Y; Shi J Adv Mater; 2014 Jun; 26(23):3867-72. PubMed ID: 24677351 [No Abstract] [Full Text] [Related]
10. Renal-Clearable Peptide-Functionalized Ba Feng Y; Chen H; Shao B; Zhao S; Wang Z; You H ACS Appl Mater Interfaces; 2018 Aug; 10(30):25511-25518. PubMed ID: 29989405 [TBL] [Abstract][Full Text] [Related]
11. Mesoporous NaYbF4@NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging. Zhou L; Zheng X; Gu Z; Yin W; Zhang X; Ruan L; Yang Y; Hu Z; Zhao Y Biomaterials; 2014 Aug; 35(26):7666-78. PubMed ID: 24929618 [TBL] [Abstract][Full Text] [Related]
12. NaGdF4:Yb(3+)/Er(3+)@NaGdF4:Nd(3+)@Sodium-Gluconate: Multifunctional and Biocompatible Ultrasmall Core-Shell Nanohybrids for UCL/MR/CT Multimodal Imaging. Ma D; Meng L; Chen Y; Hu M; Chen Y; Huang C; Shang J; Wang R; Guo Y; Yang J ACS Appl Mater Interfaces; 2015 Aug; 7(30):16257-65. PubMed ID: 26161913 [TBL] [Abstract][Full Text] [Related]
13. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI. Faucher L; Tremblay M; Lagueux J; Gossuin Y; Fortin MA ACS Appl Mater Interfaces; 2012 Sep; 4(9):4506-15. PubMed ID: 22834680 [TBL] [Abstract][Full Text] [Related]
14. Metabolomics-derived biomarkers for biosafety assessment of Gd-based nanoparticle magnetic resonance imaging contrast agents. Xu C; Sun J; Zhang C; Yang L; Kan H; Zhang D; Xue G; Dong K Analyst; 2024 Feb; 149(4):1169-1178. PubMed ID: 38205835 [TBL] [Abstract][Full Text] [Related]
15. Tumor-Targeted and Clearable Human Protein-Based MRI Nanoprobes. Zhao Y; Peng J; Li J; Huang L; Yang J; Huang K; Li H; Jiang N; Zheng S; Zhang X; Niu Y; Han G Nano Lett; 2017 Jul; 17(7):4096-4100. PubMed ID: 28581764 [TBL] [Abstract][Full Text] [Related]
16. The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances. Li X; Sun Y; Ma L; Liu G; Wang Z Molecules; 2020 Nov; 25(21):. PubMed ID: 33139643 [TBL] [Abstract][Full Text] [Related]
17. In Vivo Tumor Visualization through MRI Off-On Switching of NaGdF Yi Z; Luo Z; Barth ND; Meng X; Liu H; Bu W; All A; Vendrell M; Liu X Adv Mater; 2019 Sep; 31(37):e1901851. PubMed ID: 31364218 [TBL] [Abstract][Full Text] [Related]
18. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles. Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318 [TBL] [Abstract][Full Text] [Related]
19. NaGdF4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts in vivo. Hou Y; Qiao R; Fang F; Wang X; Dong C; Liu K; Liu C; Liu Z; Lei H; Wang F; Gao M ACS Nano; 2013 Jan; 7(1):330-8. PubMed ID: 23199030 [TBL] [Abstract][Full Text] [Related]
20. Conjugation of NaGdF4 upconverting nanoparticles on silica nanospheres as contrast agents for multi-modality imaging. Liu F; He X; Liu L; You H; Zhang H; Wang Z Biomaterials; 2013 Jul; 34(21):5218-25. PubMed ID: 23591393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]